Q2 2025 Holdings
Filed 2025-07-22 | 660 holdings | $5.0B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Q32 Bio Inc(QTTB) | Common Stock | 746964105 | $393 | 264 | 0.0% |
| OnKure Therapeutics Inc(OKUR) | Common Stock | 68277Q105 | $748 | 313 | 0.0% |
| Mersana Therapeutics Inc | Common Stock | 59045L106 | $768 | 2,594 | 0.0% |
| IGM Biosciences Inc(1K0) | Common Stock | 449585108 | $802 | 716 | 0.0% |
| PepGen Inc(PEPG) | Common Stock | 713317105 | $897 | 808 | 0.0% |
| Artiva Biotherapeutics Inc(ARTV) | Common Stock | 04317A107 | $911 | 603 | 0.0% |
| Acrivon Therapeutics Inc(ACRV) | Common Stock | 004890109 | $919 | 772 | 0.0% |
| Sutro Biopharma Inc | Common Stock | 869367102 | $1.4K | 1,982 | 0.0% |
| Pyxis Oncology Inc(PYXS) | Common Stock | 747324101 | $1.6K | 1,429 | 0.0% |
| Biomea Fusion Inc(BMEA) | Common Stock | 09077A106 | $1.6K | 899 | 0.0% |
| Pliant Therapeutics Inc(PLRX) | Common Stock | 729139105 | $1.8K | 1,509 | 0.0% |
| TScan Therapeutics Inc(TCRX) | Common Stock | 89854M101 | $1.8K | 1,218 | 0.0% |
| MacroGenics Inc(MGNX) | Common Stock | 556099109 | $1.9K | 1,557 | 0.0% |
| Climb Bio Inc(CLYM) | Common Stock | 28658R106 | $2.0K | 1,616 | 0.0% |
| C4 Therapeutics Inc(CCCC) | Common Stock | 12529R107 | $2.5K | 1,751 | 0.0% |
| Neumora Therapeutics Inc(NMRA) | Common Stock | 640979100 | $2.8K | 3,883 | 0.0% |
| Ironwood Pharmaceuticals Inc(IRWD) | Common Stock | 46333X108 | $2.8K | 3,971 | 0.0% |
| Nkarta Inc(NKTX) | Common Stock | 65487U108 | $2.9K | 1,751 | 0.0% |
| Fate Therapeutics Inc(FATE) | Common Stock | 31189P102 | $3.1K | 2,737 | 0.0% |
| Kyverna Therapeutics Inc(KYTX) | Common Stock | 501976104 | $3.3K | 1,070 | 0.0% |
| Lexeo Therapeutics Inc(LXEO) | Common Stock | 52886X107 | $3.3K | 820 | 0.0% |
| Alector Inc(ALEC) | Common Stock | 014442107 | $3.4K | 2,429 | 0.0% |
| Compass Pathways Plc(CMPS) | ADR | 20451W101 | $3.5K | 1,261 | 0.0% |
| Enanta Pharmaceuticals Inc(ENTA) | Common Stock | 29251M106 | $4.0K | 525 | 0.0% |
| Voyager Therapeutics Inc(VYGR) | Common Stock | 92915B106 | $4.2K | 1,355 | 0.0% |
| 4D Molecular Therapeutics Inc(FDMT) | Common Stock | 35104E100 | $4.3K | 1,147 | 0.0% |
| Omeros Corp(OMER) | Common Stock | 682143102 | $4.4K | 1,483 | 0.0% |
| Larimar Therapeutics Inc(LRMR) | Common Stock | 517125100 | $4.6K | 1,583 | 0.0% |
| Editas Medicine Inc(EDIT) | Common Stock | 28106W103 | $4.6K | 2,113 | 0.0% |
| Cargo Therapeutics Inc(CRGX) | Common Stock | 14179K101 | $4.7K | 1,142 | 0.0% |
| scPharmaceuticals Inc(SCPH) | Common Stock | 810648105 | $4.7K | 1,242 | 0.0% |
| Solid Biosciences Inc(SLDB) | Common Stock | 83422E204 | $4.8K | 991 | 0.0% |
| Design Therapeutics Inc(DSGN) | Common Stock | 25056L103 | $4.9K | 1,449 | 0.0% |
| Codexis Inc(CDXS) | Common Stock | 192005106 | $4.9K | 2,019 | 0.0% |
| Esperion Therapeutics Inc(ESPR) | Common Stock | 29664W105 | $5.0K | 5,045 | 0.0% |
| AC Immune SA(ACIU) | Common Stock | H00263105 | $5.0K | 2,454 | 0.0% |
| Y-mAbs Therapeutics Inc(YMABUSD) | Common Stock | 984241109 | $5.0K | 1,111 | 0.0% |
| Inhibrx Biosciences Inc(INBX) | Common Stock | 45720N103 | $5.1K | 359 | 0.0% |
| Tevogen Bio Holdings Inc(TVGN) | Common Stock | 88165K101 | $5.3K | 4,207 | 0.0% |
| OmniAb Inc(OABI) | Common Stock | 68218J103 | $5.4K | 3,099 | 0.0% |
| Neurogene Inc(NGNE) | Common Stock | 64135M105 | $5.5K | 368 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | Common Stock | 77313F106 | $5.7K | 2,333 | 0.0% |
| MaxCyte Inc(MXCT) | Common Stock | 57777K106 | $5.9K | 2,701 | 0.0% |
| Entergy Corp(ETR) | Common Stock | 29364G103 | $6.0K | 72 | 0.0% |
| Olema Pharmaceuticals Inc(OLMA) | Common Stock | 68062P106 | $6.1K | 1,422 | 0.0% |
| Allogene Therapeutics Inc(ALLO) | Common Stock | 019770106 | $6.1K | 5,368 | 0.0% |
| Third Harmonic Bio Inc(THRD) | Common Stock | 88427A107 | $6.1K | 1,118 | 0.0% |
| Inozyme Pharma Inc | Common Stock | 45790W108 | $6.2K | 1,544 | 0.0% |
| Corvus Pharmaceuticals Inc(CRVS) | Common Stock | 221015100 | $6.4K | 1,594 | 0.0% |
| Entrada Therapeutics Inc(TRDA) | Common Stock | 29384C108 | $6.4K | 958 | 0.0% |